hero section gradient
5 handpicked stocks

Penny Stocks to Watch

Looking for the next big thing at a small price? This carefully selected group of stocks under $5 has caught the attention of professional hedge funds. These hidden gems might offer significant growth potential for investors willing to take on some risk.

Author avatar

Han Tan | Market Analyst

Published on May 27

Your Basket's Financial Footprint

The basket's total market capitalisation and the dominance of a single large-cap constituent, with investor takeaways.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad-market moves.
  • Treat as a core, long-term holding within diversified portfolios rather than a speculative trade.
  • Expect steady, long-term appreciation potential; avoid expecting explosive short-term gains.
Total Market Cap
  • MDIA: $102.35M

  • ELDN: $208.99M

  • IBIO: $22.48M

  • Other

About This Group of Stocks

1

Our Expert Thinking

We follow the smart money. These penny stocks have significant hedge fund holdings, leveraging the extensive research these professional investors conduct before investing. Their substantial positions may signal confidence in these companies' growth potential.

2

What You Need to Know

Penny stocks (under $5 per share) can be highly volatile but potentially rewarding. While they offer possible substantial returns, they also carry significant risks. Consider allocating only a small portion of your portfolio to these investments.

3

Why These Stocks

These specific stocks were selected because they combine the growth potential of penny stocks with the validation of hedge fund backing. Rather than random selections, each company has attracted professional investor interest despite their current low share prices.

Why You'll Want to Watch These Stocks

🔍

Hidden Value Potential

These under-the-radar companies might be small now, but professional hedge funds have spotted something promising. Their low share prices could mean big percentage gains if they succeed.

💰

Small Investment, Big Possibilities

With share prices under $5, you can start investing with a smaller amount of money while still owning complete shares. This accessibility opens doors for investors at any level.

🧠

Smart Money Is Already In

Hedge funds have already done extensive research and invested significantly in these stocks. By following their lead, you're leveraging professional analysis that would be nearly impossible to do yourself.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions